| Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab K Yonesaka, K Zejnullahu, I Okamoto, T Satoh, F Cappuzzo, J Souglakos, ... Science translational medicine 3 (99), 99ra86-99ra86, 2011 | 705 | 2011 |
| Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients F Cappuzzo, A Marchetti, M Skokan, E Rossi, S Gajapathy, L Felicioni, ... Journal of clinical oncology 27 (10), 1667-1674, 2009 | 623 | 2009 |
| Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer KD Davies, AT Le, MF Theodoro, MC Skokan, DL Aisner, EM Berge, ... Clinical Cancer Research 18 (17), 4570-4579, 2012 | 534 | 2012 |
| Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis L Di Tommaso, G Franchi, YN Park, B Fiamengo, A Destro, E Morenghi, ... Hepatology 45 (3), 725-734, 2007 | 528 | 2007 |
| A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial M Infante, S Cavuto, FR Lutman, G Brambilla, G Chiesa, G Ceresoli, ... American journal of respiratory and critical care medicine 180 (5), 445-453, 2009 | 481 | 2009 |
| Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia International Consensus Group for Hepatocellular Neoplasia Hepatology 49 (2), 658-664, 2009 | 460 | 2009 |
| Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography M Infante, S Cavuto, FR Lutman, E Passera, M Chiarenza, G Chiesa, ... American journal of respiratory and critical care medicine 191 (10), 1166-1175, 2015 | 412 | 2015 |
| PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer E Bonavita, S Gentile, M Rubino, V Maina, R Papait, P Kunderfranco, ... Cell 160 (4), 700-714, 2015 | 382 | 2015 |
| MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients F Cappuzzo, PA Jänne, M Skokan, G Finocchiaro, E Rossi, C Ligorio, ... Annals of oncology 20 (2), 298-304, 2009 | 350 | 2009 |
| The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma L Di Tommaso, A Destro, JY Seok, E Balladore, L Terracciano, ... Journal of hepatology 50 (4), 746-754, 2009 | 342 | 2009 |
| EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients F Cappuzzo, G Finocchiaro, E Rossi, PA Jänne, C Carnaghi, C Calandri, ... Annals of Oncology 19 (4), 717-723, 2008 | 327 | 2008 |
| Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis JC Nault, J Calderaro, L Di Tommaso, C Balabaud, ES Zafrani, ... Hepatology 60 (6), 1983-1992, 2014 | 323 | 2014 |
| M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro M Leidi, E Gotti, L Bologna, E Miranda, M Rimoldi, A Sica, M Roncalli, ... The Journal of Immunology 182 (7), 4415-4422, 2009 | 322 | 2009 |
| Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples D Baumhoer, L Tornillo, S Stadlmann, M Roncalli, EK Diamantis, ... American journal of clinical pathology 129 (6), 899-906, 2008 | 306 | 2008 |
| cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation E Brunt, S Aishima, PA Clavien, K Fowler, Z Goodman, G Gores, A Gouw, ... Hepatology 68 (1), 113-126, 2018 | 304 | 2018 |
| Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer A Malesci, L Laghi, P Bianchi, G Delconte, A Randolph, V Torri, ... Clinical Cancer Research 13 (13), 3831-3839, 2007 | 291 | 2007 |
| CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study L Laghi, P Bianchi, E Miranda, E Balladore, V Pacetti, F Grizzi, P Allavena, ... The lancet oncology 10 (9), 877-884, 2009 | 279 | 2009 |
| Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer HS Parra, R Cavina, F Latteri, PA Zucali, E Campagnoli, E Morenghi, ... British journal of cancer 91 (2), 208-212, 2004 | 278 | 2004 |
| Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ... Journal of hepatology 39 (2), 208-214, 2003 | 260 | 2003 |
| Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study M Borzio, S Bruno, M Roncalli, GC Mels, G Ramella, F Borzio, G Leandro, ... Gastroenterology 108 (3), 812-817, 1995 | 247 | 1995 |
